YBX1 and mesothelioma: Entinostat was found to decrease the deacetylation of Y-box-binding protein 1 (YB-1), a pro-tumorigenic nucleic acid-binding protein upregulated in mesothelioma, causing the reduction of mesothelioma cell proliferation.